Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,476.00    36.00 (2.50%)
Bid:
1,470.00
Ask:
1,478.00
Spread: 8.00 (0.544%)
Market Cap: £505.34m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Channel Partner Contract Win

28 Feb 2012 07:00

RNS Number : 2245Y
Craneware plc
28 February 2012
 



Craneware plc

("Craneware" or the "Company")

 

Multi-million Dollar Channel Partner Contract Win

 

28 February 2012 - Craneware plc (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, is pleased to announce a new multi-million dollar channel partner, extending Craneware's reach into Federal and State sectors for all the Craneware product families.

 

Although specific terms of the reseller agreement are confidential, Craneware will receive from the channel partner, guaranteed minimum payments of $7,500,000 between now and 30 June 2014. The Channel Partner will use multi-year licenses for all of the Craneware Solutions in its work with Federal and State Healthcare facilities and projects. Following the end of the minimum period, Craneware will continue to license its solutions to those facilities that have been signed during the period of the agreement and recognise revenue on a normal basis until the end of the individual multi-year contracts.

 

This contract is the second recent channel partner deal for Craneware in as many months, demonstrating the success of its channel partner development work. These channel partner agreements provide for guaranteed minimum levels of revenue in the current and future years and extend the Company's market opportunity. As announced in the Company's Interim Results this morning, Craneware currently has several additional large channel partner deals in process.

 

This new contract reinforces the Board's confidence in the value of the new Craneware InSight solutions to the Craneware suite as they have been instrumental in winning this contract.

Keith Neilson, CEO of Cranewarecommented: "We are delighted to have signed this significant new Channel Partnership, which is a strong endorsement of product families. We continue to make progress with several other large channel partner opportunities, which combined with the two announced in recent weeks further underline the Board's confidence in current and future years."

 

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Newgate Threadneedle

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7653 9850

Keith Neilson, CEO

Dan Webster

Caroline Evans-Jones

Craig Preston, CFO

Richard Kauffer

Fiona Conroy

 

About Craneware

 

Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Boston, Nashville and Scottsdale employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance for healthcare organisations. Craneware's market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge, code and retain earned revenue for patient care services and supplies. This optimises reimbursement, increases operational efficiency and minimises compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com and stoptheleakage.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTUBAWRUBAUUAR
Date   Source Headline
31st Mar 20175:04 pmRNSDividend Currency Election
27th Mar 20176:26 pmRNSGrant of Options & Long Term Incentive Plan Award
23rd Mar 20177:00 amRNSSignificant Contract Win
7th Mar 20177:00 amRNSHalf-year Report
31st Jan 20177:00 amRNSDirector/PDMR Shareholding
17th Jan 20177:00 amRNSTrading Update
11th Nov 20164:46 pmRNSDividend Currency Election
11th Nov 20163:03 pmRNSTotal Voting Rights
11th Nov 201612:06 pmRNSBlock listing Interim Review
8th Nov 20166:08 pmRNSResult of AGM
8th Nov 20167:00 amRNSAGM Statement
31st Oct 20165:03 pmRNSPosting of Annual Report and Notice of AGM
7th Oct 20167:00 amRNSGrant of Options - Replacement
6th Oct 201611:02 amRNSTotal Voting Rights
20th Sep 20167:00 amRNSDirector/PDMR Shareholding
13th Sep 20162:48 pmRNSGrant of Options
6th Sep 20167:00 amRNSFinal Results
10th Aug 20168:26 amRNSHolding(s) in Company
6th Jul 20167:00 amRNSTrading Update, Contract Win and Notice of Results
4th Jul 201611:11 amRNSHolding(s) in Company
13th May 20167:00 amRNSTotal Voting Rights
22nd Apr 20161:04 pmRNSBlock listing Interim Review
11th Apr 20167:00 amRNSTotal Voting Rights
18th Mar 201610:44 amRNSDividend Currency Election
9th Mar 20167:00 amRNSGrant of Options
8th Mar 20167:00 amRNSHalf Yearly Report
10th Feb 20161:55 pmRNSTotal Voting Rights
2nd Feb 20167:00 amRNSSignificant Contract Win and Reseller Agreement
22nd Jan 20167:00 amRNSTrading Update
30th Nov 20155:04 pmRNSTotal Voting Rights
20th Nov 20152:26 pmRNSDividend Currency Election
17th Nov 201510:29 amRNSResult of AGM
17th Nov 20157:00 amRNSAGM Statement
13th Nov 20153:50 pmRNSHolding(s) in Company
21st Oct 20157:00 amRNSPosting of Annual Report & Notice of AGM
16th Oct 201512:44 pmRNSBlocklisting Interim Review
8th Sep 20157:00 amRNSFinal Results
16th Jul 20157:00 amRNSTrading Update and Notice of Results
27th Mar 20159:35 amRNSDividend Currency Election
10th Mar 20157:03 amRNSInterim Results
10th Mar 20157:03 amRNSStrategic Partnership with Aridhia Informatics
11th Feb 20157:00 amRNSNotice of Results
14th Jan 20157:00 amRNSTrading Update
14th Nov 201412:10 pmRNSDividend Currency Election
11th Nov 20143:35 pmRNSResult of AGM
11th Nov 20147:00 amRNSAGM Statement
17th Oct 20147:00 amRNSPosting of Annual Report & Notice of AGM
16th Oct 201412:05 pmRNSBlocklisting Interim Review
15th Oct 20147:00 amRNSDirector/PDMR Shareholding
7th Oct 201411:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.